Mylan Pharmaceuticals Inc. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2021-00881
Filing Date May 5, 2021
Institution Decision Date Nov 10, 2021
Decision Date Nov 9, 2022
Court Patent Trial and Appeal Board
Status Instituted
Appeal2023-1396
Administrative JudgesErica A. Franklin, John G. New, Susan L. C. Mitchell
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26
Claims Instituted: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26
Petitioner
Patent Owner
Petitioner Attorneys
20Viatris Inc.
Attorney Name: Paul John Molino
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: William A. Rakoczy
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Heinz J. Salmen
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Neil B. McLaughlin
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Teresa Stanek Rea
Crowell & Moring
Viatris Inc.
Attorney Name: Deborah H. Yellin
Crowell & Moring
Viatris Inc.
Attorney Name: Shannon M. Lentz
Crowell & Moring
Viatris Inc.
Attorney Name: Eric R. Hunt
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Lora M. Green
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Yahn Lin Chu
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Thomas H. Ehrich
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Steven J. Birkos
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Scott G. Bell
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Deanne M. Mazzochi
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Jeffrey A. Marx
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Thomas A. Albini
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Mary Gerritsen
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Thomas A. Albini
Rakoczy Molino Mazzochi Siwik
Viatris Inc.
Attorney Name: Ivan T. Hofmann
Rakoczy Molino Mazzochi Siwik
Patent Owner Attorneys
14Regeneron Pharmaceuticals
Attorney Name: Amanda K. Antons
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Victoria Reines
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Rebecca L. Neubauer
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Alice Ho
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Daniel L. Reisner
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: David A. Caine
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Jeremy D. Cobb
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Matthew Wilk
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: David Brown
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Attorney Name: Diana V. Do
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Richard Manning
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Lucian V. Del Priore
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Alexander M. Klibanov
Arnold & Porter Kaye Scholer
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09254338 | Use of a VEGF antagonist to treat angiogenic eye disorders | Feb 9, 2016 |
